Literature DB >> 26636546

Two Fatal Cases of Accidental Intrathecal Vincristine Administration: Learning from Death Events.

Thirachit Chotsampancharoen, Pornpun Sripornsawan, Malai Wongchanchailert.   

Abstract

We report 2 cases of accidental intrathecal vincristine administration. These injections were scheduled as intravenous injections of vincristine at the same time as other intrathecal drugs were scheduled. The mistakes were recognized immediately after administration, and a lumbar puncture was performed to lavage the cerebrospinal fluid (CSF) immediately after the incident. However, both cases developed progressive sensorimotor and radiculo-myelo-encephalopathy and the patients died 3 and 6 days after the incidents due to decerebration. A number of cases of accidental intrathecal vincristine administration have occurred in recent years in other settings, and we add our events to emphasize the need for a preventative and strictly followed protocol in oncology treatment units to prevent further unnecessary deaths. The best 'cure' for mistakenly administered vincristine via lumbar puncture is prevention, which can be improved by strict adherence to a comprehensive guideline. Oncologic treatment centers should be aware of this guideline and evaluate their protocol for vincristine administration to prevent future incidents. Based on our past experiences, we strongly recommend 'time-independent' procedures to prevent this type of incident.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26636546     DOI: 10.1159/000441380

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

Review 1.  Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.

Authors:  Joël Schlatter; David Nguyen; Michèle Zamy; Sofiane Kabiche; Jean-Eudes Fontan; Salvatore Cisternino
Journal:  Eur Spine J       Date:  2017-11-18       Impact factor: 3.134

Review 2.  Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors.

Authors:  Jessica I Griffith; Sneha Rathi; Wenqiu Zhang; Wenjuan Zhang; Lester R Drewes; Jann N Sarkaria; William F Elmquist
Journal:  Pharmaceutics       Date:  2020-12-11       Impact factor: 6.321

3.  Adverse Effects of Vincristine Chemotherapy on Cell Changes in Seminiferous Tubules and Cetrorelix GnRH Antagonistzzm321990Inhibitory Effects in Mice

Authors:  Fatemeh Nikpour; Hamid Tayefi; Daryosh Mohammadnejad; Abolfazl Akbarzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

Review 4.  Neuraxial and peripheral misconnection events leading to wrong-route medication errors: a comprehensive literature review.

Authors:  Eugene R Viscusi; Vincent Hugo; Klaus Hoerauf; Frederick S Southwick
Journal:  Reg Anesth Pain Med       Date:  2020-11-03       Impact factor: 6.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.